miR-370 regulates ISG15 expression and influences IFN-α sensitivity in hepatocellular carcinoma cells [0.03%]
miR-370通过调节ISG15的表达影响肝癌细胞对IFN-α的敏感性
Zhuo Liu,Min Ma,Lei Yan et al.
Zhuo Liu et al.
Background: Interferon-α (IFN-α) is an adjuvant to chemotherapy and radiotherapy for hepatocellular carcinoma (HCC), but some HCC patients do not respond to treatment with IFN-α. ...
MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma [0.03%]
microRNA-493通过靶向ZFX抑制人类肝癌细胞的增殖和侵袭
Wei Ding,Hongbo Tan,Xuemei Li et al.
Wei Ding et al.
Backgrounds: MicroRNAs (miRNAs) are some RNA molecules that negatively regulate gene expression by binding to the 3'-untranslated region (3'-UTR) of target mRNA molecules. The aim of the study is to investigate the clinic...
Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer [0.03%]
上皮间质转化和CTC中GALC表达在非小细胞肺癌转移和预后中的作用
De-Gang Liu,Lei Xue,Jun Li et al.
De-Gang Liu et al.
Background: Circulating tumor cells (CTCs) is a promising biomarker for cancer prognosis and monitoring. Molecular characterizing of CTCs could provide beneficial information on the basis of CTCs counting. ...
Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer [0.03%]
血浆CCL5促进局部晚期乳腺癌向表 epithelial-mesenchymal transition介导的表柔比星耐药性
Ge Ma,Huaxing Huang,Minghui Li et al.
Ge Ma et al.
Neoadjuvant chemotherapy (NCT) is the standard treatment for locally advanced breast cancer (LABC). Pathological complete response (pCR) is commonly used as a valid predictor of NCT long-term outcomes. Blood-based tumor biomarkers have the ...
The emerging roles of long non-coding RNA in gallbladder cancer tumorigenesis [0.03%]
长非编码RNA在胆囊癌发生中的作用不容忽视
Bing Chen,Ya Li,Yuting He et al.
Bing Chen et al.
Accumulating evidence suggests that long non-coding RNAs (lncRNAs) have important regulatory functions in gallbladder cancer (GBC) tumorigenesis and can serve as potential novel markers and/or targets for GBC. In this review, we critically ...
The roles of CD133 expression in the patients with non-small cell lung cancer [0.03%]
CD133表达在非小细胞肺癌患者中的作用研究
Dan Wang,Gui-Min Wen,Wei Hou et al.
Dan Wang et al.
Background: This study was carried out to investigate the correlation between CD133 and non-small cell lung cancer (NSCLC) clinicopathological features and its impact on survival of the patients with NSCLC. ...
Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients [0.03%]
Rap1GAP表达降低作为胃癌患者的预后生物标志物
Jingjing Zhao,Cong Mai,Desheng Weng et al.
Jingjing Zhao et al.
Background: Rap1GAP, a member of the family of GTPase-activating proteins, is reported to be involved in cancer development and progression. Objective: ...
Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer [0.03%]
SNHG3表达上调与预后不良及卵巢癌恶性进展增强有关
Lan Hong,Wangsheng Chen,Dongcai Wu et al.
Lan Hong et al.
Background: Aberrant expression of long non-coding RNAs is involved in the progression of ovarian cancer. However, the clinical significance and biological functions of SNHG3 expression was little known in ovarian cancer ...
Published Erratum
Cancer biomarkers : section A of Disease markers. 2018;22(1):175. DOI:10.3233/CBM-179671 2018
Published Erratum
Cancer biomarkers : section A of Disease markers. 2018;22(1):177. DOI:10.3233/CBM-179650 2018